BOARD OF DIRECTORS
Gregory L. Heacock, PhD
Chief Executive Officer, Co-Founder
Dr Heacock has more than 30 years’ experience of managing companies and teams that develop and introduce new medical devices for ophthalmic, oncology and dermatology applications. His work has resulted in more than 90 new product launches and over 50 patents and patent applications. He has extensive experience obtaining regulatory approvals in the CDRH and ISO environments, including Class I to Class III devices and therapeutics.
Dr Heacock holds a B.Sc. in Manufacturing Engineering from Central Washington University and a Ph.D. within the Faculty of Medicine in the field of bioengineering from the University of London, UK.
Louise E. Culham, PhD, MPhil, MCOptom
Executive Vice President, Co-Founder
Previously Head of Optometry at Moorfields Eye Hospital, London UK, Dr Culham directed all operations for the largest ophthalmic clinical support unit in Europe which served more than 250 patients per day. At the same time, Dr Culham held an academic position at the Institute of Ophthalmology, London undertaking novel research and supervising several PhD students. Her work has resulted in more than 30 publications in peer reviewed journals.
Dr Culham holds a B.Sc. (Hons.) Ophthalmic Optics and Visual Science, a Diploma in Optometry (clinical qualification), a Master of Philosophy Degree and a Ph.D., both from Faculty of Medicine, University of London.
Jean Dudek Kuelper
Board Member
Previously a managing partner of an intellectual property law firm, McAndrews Held & Malloy, Ms Kuelper has represented Fortune 500, mid-size and startup companies as well as several Universities in patent matters involving technologies including medical devices, software, electronics, telecommunications, optics and lasers. As lead trial counsel in patent litigation, she has obtained multimillion dollar awards. She has also negotiated complex multi-party technology licenses and patent royalties of 10% and higher. She has developed patent portfolios and strategies for several startup companies that were sold for tens of millions of dollars.
Tad Swanson
Board Member
Mr Swanson has been an active entrepreneur, executive, investor and business strategist for over 30 years. His career includes various roles in large enterprises as well as over 100 innovative start-ups and emerging growth businesses within numerous industries, including internet, social, hardware, software, data, consumer products, medical/health, environment, entertainment and apparel/footwear. Since 1998, he has been President of Bridger Capital & Strategy, a Northern Rockies venture and strategy firm. In 2006, Mr. Swanson received the “Volunteer of the Year” award from Max Baucus, U.S. Senator and Chairman of the Senate Finance Committee, and TechRanch, a technology incubator. Mr Swanson holds an Industrial Engineering degree from Stanford University.
Peter Falzon MBA
Board Member
Mr Falzon is a medical device industry executive with 25 years of experience recruiting and building industry leading management teams. The expertise he brings to Sensor Indicator Products includes public company CEO skills, international sales and marketing and early stage start-up experience. With a strong background in finance, sales management, marketing and business development, Peter has a proven track record growing commercial operations for medical companies. He has held executive positions at Coherent Medical, Cutera, and Ellex among others in the medical device industry. He is currently President and CEO of Ripple Science, a venture stage clinical trial software company spun out of the University of Michigan Office of Technology Transfer. Peter holds a BA in Economics and Japanese Studies from the University of Michigan and has studied at Nanzan University in Nagoya, Japan. In addition, he has a MBA with distinction from the University of Michigan Ross School of Business.
COMPANY ADVISORS
Andrew Mills, PhD
Professor Mills gained a first class honors degree in Chemistry from the University of London (Westfield College, UK) in 1979 and was at the same time awarded the Neil Arnott award for the best degree in Chemistry in the University of London for that year. His PhD on the photodissociation of water was carried out at the Royal Institution of Great Britain, supervised by the Nobel Laureate Lord George Porter, PRS. At 24 he took up a lectureship at Swansea University in the Department of Chemistry. In 1995, aged 38 Professor Mills was awarded a personal Chair in Chemistry, and in 1999 left for the University of Strathclyde (Glasgow, Scotland) to take up a Chair in Physical Chemistry in the Department of Pure and Applied Chemistry, and subsequently joined the staff at Queen’s University, Belfast in 2011. Professor Mills’ research interests include: dye and semiconductor photochemistry, redox catalysis, optical gas sensing and intelligent indicators and plastics for packaging and other applications.
William F. Quirk, MD, FACEP
Dr Quirk is a Stanford-trained, board certified emergency physician practicing in Denver, Colorado. He is also the Chief Medical Officer of dBMEDx, Inc a medical device company specializing in ultrasound solutions. In 2012, as CMO of Ascend Billing Systems (ABS), he helped transition and sell ABS to Intermedix, Inc. Prior to that transaction he was an initial investor in iTriage, a novel medical app and IT platform, which was sold to Aetna in 2011. Dr Quirk consults for the Colorado Board of Medical Examiners and was named to the Board of Directors of CarnotMD, Inc in April 2014. CarnotMD provides cost-effective cloud based medical practice IT services.
Garry Sandhu, MD
Dr Sandhu is a Washington University-trained, double board certified Urologic Oncologist practicing in Quincy, Illinois. He has served in a consulting capacity with numerous medical and surgical device companies including Intuitive Surgical, Fuji, American Medical Systems, Boston Scientific, and C.R. Bard, Inc. He has an extensive background in prior research and development with surgical devices with the above companies and offers valuable insight into the medical/surgical applicability of our products.